Company
United StatesRichard W. Foltin, Ph.D., New York, NY – FDA Inspections
Inspection records and compliance data for Richard W. Foltin, Ph.D. in New York, New York. 2 FDA inspections on record (1 OAI), 2 Form 483s, 1 warning letter, last inspected March 17, 2023.
Company Profile
This profile covers Richard W. Foltin, Ph.D. based in New York, New York, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 1
- VAI
- 1
- NAI
- 0
- Form 483s
- 2
- Warning letters
- 1
First inspected June 21, 2019. Last inspected March 17, 2023.
Most cited issue areas
- Case history records- inadequate or inadequate1 inspection
- FD-1572, protocol compliance1 inspection
- Investigator statement (FDA 1572)1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 17, 2023 | OAI | Human Drugs · Bioresearch Monitoring | 1199985 |
| June 21, 2019 | VAI | Human Drugs · Bioresearch Monitoring | 1093938 |
FDA documents
Form 483s (2)
Warning Letters (1)
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Healthy Choice Compounding LLC
Maimonides Medical Center - Pharmacy
Magellan Rx Pharmacy, LLC
HomeChoice Partners dba BioScript Infusion Services
Maitland Labs of Central Florida
Molecular PharmaGroup
InfuScience, Inc. dba Bioscrip Infusion Services
Edge Pharma, LLC
Innovative Compounding Pharmacy
Revive Rx LLC dba Revive Rx Pharmacy
Company Information
Name
Richard W. Foltin, Ph.D.
FEI Number
3003469576
Address
1051 Riverside Dr Unit 120, New York, New York 10032, United States
Country
United States
ID: 04a08162-904e-4999-9f8c-7d0b3b61bd18